Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Adherence to Exclusive Enteral Nutrition in Patients With Crohn's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04933214
Recruitment Status : Recruiting
First Posted : June 21, 2021
Last Update Posted : June 21, 2021
Sponsor:
Information provided by (Responsible Party):
Second Affiliated Hospital, School of Medicine, Zhejiang University

Brief Summary:
The study has not yet been completed

Condition or disease
Crohn Disease

Layout table for study information
Study Type : Observational
Estimated Enrollment : 131 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Adherence to Exclusive Enteral Nutrition in Patients With Crohn's Disease
Actual Study Start Date : May 12, 2021
Estimated Primary Completion Date : December 12, 2021
Estimated Study Completion Date : December 12, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Crohn's Disease




Primary Outcome Measures :
  1. Adherence [ Time Frame: December 2020 to May 2021 ]
    The adherence of patients was evaluated by the ratio of daily actual intake of energy to daily target energy.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   14 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
We investigated CD patients who received EEN therapy in tertiary hospital in Hangzhou from December 2020 to May 2021.
Criteria

Inclusion Criteria:

  • The main inclusion criteria were as follows: had diagnosed CD more than 3 months; had EEN in the past 6 months; were at least 18 years old; agreed to participate in this study.

Exclusion Criteria:

  • The exclusion criteria were received treatment from mental health professionals due to any mental or cognitive impairment; suffered from other serious diseases, such as heart, brain, lung, liver and kidney dysfunction; severe infection, anemia, cachexia or other serious complications were found.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04933214


Contacts
Layout table for location contacts
Contact: Zexin Chen 15867136069 keyanlunli_zheer@163.com

Locations
Layout table for location information
China
2ndAffiliated Hospital, School of Medicine, Zhejiang University, China Recruiting
Zhejiang, China
Sponsors and Collaborators
Second Affiliated Hospital, School of Medicine, Zhejiang University
Investigators
Layout table for investigator information
Study Director: Yan Chen 2ndAffiliated Hospital, School of Medicine, Zhejiang University, China
Layout table for additonal information
Responsible Party: Second Affiliated Hospital, School of Medicine, Zhejiang University
ClinicalTrials.gov Identifier: NCT04933214    
Other Study ID Numbers: 2021-0324
First Posted: June 21, 2021    Key Record Dates
Last Update Posted: June 21, 2021
Last Verified: May 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Second Affiliated Hospital, School of Medicine, Zhejiang University:
Crohn's disease, Exclusive Enteral Nutrition, Adherence
Additional relevant MeSH terms:
Layout table for MeSH terms
Crohn Disease
Inflammatory Bowel Diseases
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Intestinal Diseases